🇺🇸 Multi-strain probiotics in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 5
Most-reported reactions
- Ageusia — 1 report (20%)
- Anosmia — 1 report (20%)
- Decreased Appetite — 1 report (20%)
- Inappropriate Schedule Of Product Administration — 1 report (20%)
- Weight Decreased — 1 report (20%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Multi-strain probiotics approved in United States?
Multi-strain probiotics does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Multi-strain probiotics in United States?
Seoul National University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.